Cargando…
A new treatment for severe pulmonary arterial hypertension based on an old idea: inhibition of 5-lipoxygenase
It has been generally accepted that severe forms of pulmonary arterial hypertension are associated with inflammation. Plasma levels in patients with severe pulmonary arterial hypertension show elevated levels of interleukins and mediators of inflammation and histologically the diseased small pulmona...
Autores principales: | Voelkel, Norbert F., Peters-Golden, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103594/ https://www.ncbi.nlm.nih.gov/pubmed/32257113 http://dx.doi.org/10.1177/2045894019882635 |
Ejemplares similares
-
Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension
por: Sakao, Seiichiro, et al.
Publicado: (2015) -
Massive dilatation of the pulmonary artery in association with pulmonic stenosis and pulmonary hypertension
por: Morjaria, Sejal, et al.
Publicado: (2012) -
HIV X4 Variants Increase Arachidonate 5-Lipoxygenase in the Pulmonary Microenvironment and are associated with Pulmonary Arterial Hypertension
por: Almodovar, Sharilyn, et al.
Publicado: (2020) -
Estrogen exposure, obesity and thyroid disease in women with severe pulmonary hypertension
por: Sweeney, Lori, et al.
Publicado: (2009) -
Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation
por: Sakao, Seiichiro, et al.
Publicado: (2009)